This presentation explores ethical culture by viewing how Johnson & Johnson used its credo (code) to respond to the 1982 Tylenol cyanide poisoning. J&J did a worldwide recall, instead of a local one, costing the company millions of additional dollars. They did this even though the FBI and the FDA asked them not to conduct a recall, but J&J thought this was in the best interest of their customers. They maintained the consumer’s trust and confidence, and Tylenol remains a market leader today. Fast forward 30 years, and J&J seems to have a different “tone”, driven more by profits, instead of ethics. Recall after recall has taken its toll on J&J reputation, and its stock price.
For more information contact Carol Turchick. firstname.lastname@example.org or 513-745-2936.
Click here to download a PDF program brochure including an overview, benefits, facilitator information and other program details.
This program typically runs 60-75 minutes but can be tailored to meet the specific needs of organization.
Professor Paul Fiorelli is the Director of the Cintas Institute for Business Ethics at Xavier University. Professor Paul Fiorelli has been the lead faculty on over 20 international trips to Europe, focusing on London and Paris. He has an extensive professional network in the Ethics and Compliance field. Professor Fiorelli received both his law and M.B.A. degrees in 1981, has taught at Xavier University since 1983 and has been a tenured, Full Professor since 1994. He has received the following teaching awards: (1) the Dean’s Award for Teaching Excellence in 2003, 2005 and 2006, (2) Teacher of the Year for the Williams College of Business in 1995 and 1997, (3) the Teacher of the Year for Executive MBA's in 1992, 1997 and 1999, and (4) the Lamp of Knowledge Teaching Award for the General Electric MBA program in 2002.
Professor Fiorelli actively advises in the area of business ethics and has provided workshops and presentations to groups and companies, including: AK Steel, AIG, ALICO, Association of College and University Auditors, Bell-Textron Helicopter, BP, Cinergy, the Conference Board, the Defense Industry Initiative, Eli Lilly & Co., Ethics and Compliance Officer Association, Ethics Resource Center, Fifth Third Bank, Fort Washington Investment Advisors, General Dynamics, Honda of America, Mead-Westvaco, Microsoft, Northrop Grumman, the Ohio Society of CPAs, Sears, Society of Corporate Compliance and Ethics, Toyota, the Practicing Law Institute, US Oncology, Wal-Mart, Walsh Construction, and Western-Southern Life Insurance.